Sonelokimab

Modify Date: 2025-08-27 17:19:31

Sonelokimab Structure
Sonelokimab structure
 Common Name Sonelokimab
CAS Number 1414386-05-2 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Sonelokimab


Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research[1][2].

 Names

Name Sonelokimab

 Sonelokimab Biological Activity

Description Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research[1][2].
Related Catalog
Target

IL-17A

IL-17F

References

[1]. Kim A Papp, et al. IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study. Lancet. 2021 Apr 24;397(10284):1564-1575.  

[2]. Martin A Rossotti, et al. Immunogenicity and humanization of single-domain antibodies. FEBS J. 2022 Jul;289(14):4304-4327.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Sonelokimab suppliers

Sonelokimab price

Related Compounds: More...
Tert-butyl 2-(4-cyanophenyl)morpholine-4-carboxylate
1824467-84-6
3-(2-Methylthiazol-4-yl)-1-(pyrrolidin-1-yl)prop-2-en-1-one
1252566-73-6
N-Methyl-N-propyl-1H-imidazole-1-carboxamide
1498924-73-4
2-{[(3-Cyanophenyl)methyl]amino}acetic acid hydrochloride
1375474-13-7
(3-Aminopropanoyl)urea hydrochloride
1375471-90-1
3-(4-(Cyclopropanecarbonyl)piperazin-1-yl)propanoic acid hydrochloride
1375990-51-4
N-(4-pyrrolidin-1-ylpyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
1419221-51-4
2-fluoro-N-(4-propylpyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
1419221-40-1
N-(4-methylpyrimidin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
1419221-35-4
Methyl 2-(5-chloro-3-iodo-1h-indazol-1-yl)propanoate
1420068-84-3
Chemsrc provides Sonelokimab(CAS#:1414386-05-2) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Sonelokimab are included as well.>> amp version: Sonelokimab

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved